Charlotte’s Web reported a difficult sales quarter for its hemp-derived CBD business while narrowing its operating loss. Revenue for the three months ended September 30, 2026 was US$9.4 million, down 18.3 percent from a year earlier. Its operating loss narrowed to US$3.7 million from US$5.3 million, showing why the direction of sales and the direction of a loss do not always match.

The company announced the results November 12 and filed its quarterly report with the U.S. Securities and Exchange Commission. The release attributes weaker revenue primarily to California restrictions that took effect in July, reduced promotional discounting and softer demand in parts of the hemp-wellness market. Those explanations are management’s account of the quarter, rather than an independent measurement of every factor affecting CBD shoppers.

Less revenue does not automatically mean a larger loss

The company’s earnings release reports quarterly gross profit of about US$4.4 million, compared with US$4.5 million a year earlier, even as sales fell. Gross margin improved to 46.9 percent from 38.9 percent. Selling, general and administrative expenses declined to US$8.1 million from US$9.7 million.

A percentage margin and a dollar profit measure answer different questions. A company can retain a larger share of each sales dollar while bringing in fewer dollars overall. Lower expenses can then narrow the operating loss without putting the business into operating profit. That is the distinction these results require.

The announcement also identifies an inventory reserve linked to simplifying the product range. Readers should therefore resist interpreting a single margin percentage as a permanent new baseline. Product mix, pricing, manufacturing costs and inventory adjustments can all affect the calculation.

The quarterly filing keeps the periods straight

The Form 10-Q records quarterly revenue more precisely at US$9.393 million and a net loss of US$3.458 million. These rounded to the US$9.4 million revenue and US$3.5 million net loss in the announcement. An operating loss and a net loss are different lines of the accounts, not conflicting reports of one number.

The nine-month picture is also distinct from the latest quarter. The release reports a US$20.7 million net loss for the first nine months, including noncash items associated with the earlier debenture conversion. It would be misleading to describe an improved third-quarter operating loss as proof that every year-to-date earnings measure improved.

The filing shows US$11.364 million of cash and cash equivalents at September 30. Cash on that date is a financial-position measure, rather than sales or profit earned during the quarter. Looking at the income statement and cash-flow statement together gives a fuller picture than treating a positive cash balance as evidence of profitability.

Hemp policy remains part of the business story

Cannabis policy is directly relevant to this CBD company because the legal definition of hemp determines which products can use that route to market. The Congressional Research Service’s October 28 legal sidebar explains that the federal delay does not move every element of the new definition to the same date. It distinguishes the treatment of certain cannabinoids not naturally produced by the plant from provisions delayed until December 11.

That distinction is useful beyond one company. A hemp-derived label does not settle a product’s future legal status, and a federal deadline does not automatically override a state’s separate rules. Consumers and businesses need to identify the applicable product definition, ingredients and jurisdiction.

Charlotte’s Web’s October 28 announcement said it planned to hold a corporate update after December 11 rather than a November earnings call, seeking greater policy clarity before discussing its outlook. That is a communications plan, not evidence that Congress will produce the outcome the company prefers.

Product access and medical evidence are separate

A financial report from a CBD business does not establish that a product treats a disease or is appropriate for a particular person. Sales trends describe commercial activity. They do not measure a clinical benefit, and a discussion of future healthcare distribution should not be mistaken for a new drug approval or a general reimbursement entitlement.

Our coverage of Willie Nelson’s hemp-policy appeal addresses the public debate over access. Charlotte’s Web’s results supply a different perspective: how a company says restrictions, pricing decisions and expenses are affecting its accounts. The two stories illuminate different parts of the same policy uncertainty.

The next meaningful business signals will include the durability of any sales recovery, spending levels and the details of the legal framework actually in force. For now, the results show a smaller quarterly operating loss alongside lower CBD revenue. They do not yet resolve whether the company can turn that improvement into sustained growth and profitability.

Illustrative empty-bottle stock photograph; not Charlotte’s Web packaging or identified CBD products. Photo: Kelly Sikkema / Unsplash.

Portland is considering removing a city-code restriction on cannabis drive-through and walk-up sales, but the proposal has not become a new retail permission. The city’s record for Ordinance 2026-407 shows the November 10 City Life Committee item was continued, with December 8 listed as its next meeting date.

The proposal introduced by Mayor Keith Wilson combines two subjects: updating the language governing exterior sales windows and revising the way licensing-payment provisions appear in city code. For cannabis shoppers, the first is about how a purchase might be collected. For operators, the second concerns the timing and administration of license costs.

A retailer considering a physical alteration would still need to assess the property and any other applicable approvals. Removing one cannabis-specific sales restriction is not the same thing as approving a building project.

The window restriction is specific

Portland’s current marijuana licensing chapter bars sales from vendor carts, temporary structures, satellite locations and exterior openings such as drive-through facilities or walk-up windows. The proposed amendment would remove the exterior-opening language while retaining restrictions on those other kinds of sales locations.

That is narrower than allowing cannabis sales anywhere a customer can drive or walk. A licensed premises would still be a particular business location, subject to the rest of its applicable requirements. The change concerns a method of serving customers, not the disappearance of the licensing system.

City materials say the amendment would align Portland’s wording with Oregon rules that made on-site delivery a permanent option in September 2020, following temporary pandemic arrangements. That history helps explain why the debate is framed as an update to conflicting language rather than a brand-new statewide retail model.

Convenience does not mean on-site consumption

One important boundary remains in the proposed code exhibit: the provision against consumption on licensed premises is retained, with its existing narrow employee exception under Oregon law. A pickup window and a consumption lounge are different activities.

The same exhibit retains operating-hour and security requirements. Its redline shows a targeted deletion concerning sales openings, rather than an across-the-board removal of the rules governing retail premises. Reading the actual proposed changes is more informative than assuming that the phrase drive-through implies a completely different type of store.

For a customer, the practical questions would still include whether a specific retailer offers a service, how the order is handled and which rules apply. A citywide code amendment, if adopted, would not guarantee that every shop installs a window or changes its property layout.

The payment provisions affect operators differently

The ordinance also addresses the Deferred Payment Program for license fees. The city’s explanation says a 50% initial payment better supports collection and that the code should refer to the council-approved fee schedule rather than preserve outdated dollar amounts.

That is a distinction between the text of the code and the administration of a program. City materials say programmatic changes were communicated in June and July and implementation began in August. The proposal would codify practices already in place, according to the city, rather than introduce every payment change for the first time.

Operators evaluating the proposal therefore need both the amended text and the applicable fee schedule. A headline about pickup windows does not explain a business’s entire licensing bill, and an old fixed amount quoted from code may not describe current program administration.

Businesses are raising questions about cash flow

In KPTV’s November 10 reporting, Mikhala Armstrong described support for greater accessibility alongside concerns from cannabis operators about payment obligations and late fees. Those interviews add an important perspective to the city’s stated goal of improving administration.

The two views are not interchangeable. The city describes its intended program effects; individual operators describe how they believe the arrangements affect their businesses. A final assessment should distinguish those accounts from evidence about what happens after implementation.

Our coverage of Missouri’s interstate cannabis guidance concerned a separate jurisdiction, but illustrates a related point: legal cannabis markets remain governed by specific rules at different levels. A state allowance does not make every local detail irrelevant.

The next step is still a public decision

The city’s document history is the place to follow whether the committee advances or amends the proposal. As of this review, its status is continued, not adopted. Readers should check the updated agenda before relying on the December meeting listing or making plans to offer a new service.

The potential change is concrete: remove a particular restriction on how licensed cannabis stores serve customers and bring fee language into line with current administration. Whether that becomes the final city policy remains the question before Portland, rather than a decision already made.

Illustrative Portland waterfront photograph; not a dispensary or proposed pickup site. Photo: Meggyn Pomerleau / Unsplash.

Weedmaps parent WM Technology reported lower revenue and a quarterly loss on November 9, offering a view of pressure on the businesses that help cannabis retailers reach customers. The results connect the shopping experience on a cannabis marketplace with a less visible concern: whether its business clients can keep paying for their presence there.

The company’s third-quarter announcement covers the period ended September 30, 2026. Revenue was $38.5 million, compared with $42.2 million a year earlier, and consolidated net loss was $5.9 million, versus net income of $3.6 million. Management attributed much of the revenue pressure to client payment difficulties.

The client count measures businesses, not shoppers

Average monthly paying clients declined to 4,899 from 5,221. Average monthly revenue per paying client was $2,618, compared with $2,693 a year earlier. Those figures describe the company’s paying business relationships; they are not a count of people browsing cannabis menus or the amount a shopper spends on flower.

That distinction matters because a marketplace serves more than one audience. The consumer may experience it as a place to discover products, compare listings or find a retailer. The paying business evaluates a different transaction: whether the service is worth its advertising or commerce budget.

A decline in paying clients therefore cannot, by itself, establish that consumer interest in cannabis fell by the same amount. Likewise, a rise in browsing activity would not automatically prove that business customers are profitable or able to pay their bills. These measures answer different questions.

California remains a major part of the picture

The quarterly filing says approximately 61% of revenue came from California in both the three-month and nine-month periods ended September 30. The corresponding share was approximately 56% a year earlier. Substantially all revenue was generated in the United States.

Geographic concentration is useful context when reading a national-sounding cannabis technology story. Results from a platform with a large exposure to one state should not be treated as a complete survey of every legal market. Different customer mixes can produce different outcomes even within the same industry.

The filing also describes the composition of nine-month revenue: Featured Listings and WM Deal products represented approximately 63%, Standard Listings 31% and other advertising solutions 6%. These are revenue categories, not measures of how much shelf space a dispensary devotes to particular products.

For an operator evaluating marketing, that breakdown suggests a useful question: what exactly is being purchased and measured? A listing, a promotional placement and a completed retail sale are different steps. Assessing them together requires evidence about the business’s own results, rather than assuming visibility automatically equals revenue.

A positive adjusted figure does not erase a loss

WM Technology reported adjusted EBITDA of approximately $0.8 million, down from $7.6 million. Adjusted EBITDA is a non-GAAP measure, with the company’s reconciliation showing adjustments beyond ordinary net income. It should be read alongside the loss, rather than presented as an interchangeable description of profitability.

There is another distinction within the reported loss itself. The consolidated figure was $5.9 million, while the amount attributable to WM Technology was approximately $4.2 million after the non-controlling-interest allocation. A headline using either number needs to identify what it measures.

For readers who do not follow earnings reports, the important point is consistency. Compare like periods and like measures. A quarterly result should not be compared casually with a nine-month total, and an adjusted measure should not be set against a prior-year net-income figure as though the labels do not matter.

The outlook is still an estimate

As of the announcement, management expected fourth-quarter revenue to decline by a low-single-digit percentage from the third quarter. It also described a planned sponsored advertising product for brands. These are forward-looking statements, not completed fourth-quarter results or proof that a new product has already generated revenue.

The next meaningful test is whether later reporting supports those expectations. A strategy can be coherent without its outcome being established. Readers should keep the reported quarter, management’s explanation and its forecast separate when judging the announcement.

Our report on Missouri’s interstate cannabis guidance concerns a different issue, but highlights why the industry cannot be understood as a single unrestricted national market. For cannabis businesses, location and operating rules remain part of the commercial context.

WM Technology’s quarter shows pressure on the business side of cannabis discovery. The useful takeaway is not a prediction about its share price or the whole industry’s direction. It is a clearer view of the measures behind a familiar marketplace: paying clients, advertising revenue, geographic exposure and the difference between current results and future plans.

Illustrative business workspace photograph; not WM Technology offices or its software. Photo: Jakub Żerdzicki / Unsplash.